Rezolute, Inc. Common Stock (NV) (RZLT)
Rezolute, Inc. (RZLT) is a biotechnology company focused on developing treatments for metabolic and rare diseases. The company's portfolio includes therapies aimed at addressing diabetes, congenital hyperinsulinism, and other underserved conditions. Rezolute specializes in innovative drug formulations and has a pipeline of product candidates progressing through clinical development.
Company News
Additional $6.7M in funding resulting in approximately $67M in gross proceeds Additional $6.7M in funding resulting in approximately $67M in gross proceeds
The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider t...
Rezolute, Inc. (RZLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.